This is an exciting time for medical diagnostics, with recent innovations allowing for faster disease diagnosis than ever before. From cancer to diabetes to heart disease, here are 10 diagnostic tests that could change the game when it comes to catching diseases earlier. Next >>
Diagnostics
AdvaMed unveils new tools to assess medical device value
AdvaMed today launched a new value initiative that includes extensive tables of questions to help medical device companies formulate value-based arguments. The value framework also includes tools specifically designed for diagnostic technologies, as well as report on understanding evidence and use cases. “Value” has become an important word in medtech in recent years as government and […]
GE Healthcare wins FDA nod for Visipaque coronary CT angiography injection
GE Healthcare (NYSE:GE) said today that it won an indication approval from the FDA for its Visipaque injection imaging agent. The 320 milligram iodine per milliliter injection is an iso-osmolar agent that the federal watchdog approved for use in coronary computed tomography angiography. The new indication allows doctors to image coronary arteries of patients to help […]
How IBM is using deep learning to detect diabetic eye disease
IBM’s deep learning technology can detect and classify the severity of diabetic retinopathy with 86% accuracy, according to new research. The diagnostic tool could help doctors and physicians better understand disease progression and determine treatment, IBM said. The company’s technology was trained to identify lesions using more than 35,000 eye images. It can classify the […]
23andMe is back: FDA allows marketing of genetic health risk tests
FDA this month allowed genetic testing company 23andMe to market genetic health risk tests for 10 diseases and conditions including Parkinson’s disease and late-onset Alzheimer’s disease. The de novo premarket review authorization, announced April 6, also included celiac disease, which results in the inability to digest gluten; alpha-1 antitrypsin deficiency, which raises the risk of […]
MeMed wins $9.2m DoD deal for diagnostic device
MeMed said today that it won a $9.2 million contract from the Defense Threat Reduction Agency, a branch of the U.S. Dept. of Defense, for its diagnostic platform that distinguishes bacterial infections from viral infections. The Israel-based company has developed a test to recognize the distinct human immune signatures of both bacterial and viral infections […]
SystemOne announces 4 new countries using GxAlert for diagnostic data
SystemOne, a connected diagnostics company developing data-driven healthcare insight and solutions, has announced 4 new GxAlert implementations in Africa and the Middle East. SystemOne develops software and networking solutions to move and make use of data from diagnostic instruments focused on infectious disease. SystemOne users receive over 20,000 instant alerts from diagnostic devices each month […]
Cerveau Technologies, Wisconsin Alzheimer’s Center ink research deal
Cerveau Technologies said today that it landed a clinical research agreement with the University of Wisconsin-Madison Alzheimer’s Research Center to study an early stage imaging agent with positron emission tomography scans to assess the status and progression of neurofibrillary tangles in the brain. Neurofibrillary tangles composed of tau protein are characteristic of certain neurodegenerative diseases, […]
DNA motors could power molecular machines for drug delivery
Researchers from the University of Alberta have developed nanomachines powered by synthetic DNA motors to improve disease detection and drug delivery. The team’s work was published this week in Nature Communications. The scientists developed the nanomachine using compartments composed of DNA enzyme molecules and substrates. “This nanomachine has the required fuels, DNA tracks, and a molecular switch,” […]
TearLab readies for reverse split
Shares in TearLab Corp. (NSDQ:TEAR) said last week that its board approved a 1-for-1o reverse split of its common stock. The company’s shares have fallen nearly 20% since the beginning of the month. The San Diego, Calif.-based company’s move reduced the total number of authorized shares of its common stock from 95 million t0 9.5 […]